Healthcare Technology Report September 9, 2024
HistoSonics, a leading developer of non-invasive histotripsy therapy platforms, has announced the completion of a $102 million Series D financing round, significantly oversubscribed and led by Alpha Wave Ventures. The round saw participation from new investors, including Amzak Health and HealthQuest Capital, along with existing backers such as Johnson & Johnson Innovation – JJDC, and Lumira Ventures.
The funds will be utilized...
Today's Sponsors
Today's Sponsor